Timber Pharmaceutical Gets FDA Fast Track designation for TMB-001 in Severe Subtypes of Congenital Ichthyosis

By: via Benzinga
Timber Pharmaceuticals, Inc. (NYSE: TMBR) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.